Studies In Prostate Cancer Reported From The United States
Jul-26-2007
Research conducted in the United States has provided new information about prostate cancer. Study 1: Scientists discuss in "Eradication of therapy-resistant human prostate tumors using a cancer terminator virus" new findings in prostate cancer. According to a study from the United States, "Terminal prostate cancer is refractory to conventional anticancer treatments because of frequent overexpression of antiapoptotic proteins Bcl-2 and/or Bcl-x(L). Adenovirus-mediated delivery of melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), a secreted cytokine having cancer-selective apoptosis-inducing properties, profoundly inhibits prostate cancer cell growth." "However, forced overexpression of Bcl-2 or Bcl-x(L) renders p...
Researchers From University Of California Publish New Prostate Cancer Data
Jul-26-2007
Data from University of California, U.S., provide new insights into prostate cancer. Study 1: Data detailed in "Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE" have been presented. According to a study from the United States, "Previous findings have suggested that patient educational attainment is related to cancer stage at presentation and treatment for localized prostate cancer, but there is little information on education and quality of life outcomes. Patient education level and quality of life were examined among men diagnosed with prostate cancer and cared for within an equal-access health care system, the Departm...
Improved Prediction Of Prostate Cancer Recurrence Through Systems Pathology
Jul-26-2007
Aureon Laboratories and their collaborators announced the publication of their 'Systems Pathology' model for predicting prostate cancer PSA recurrence in the Journal of Clinical Investigation (JCI). The article supports the Prostate Px(R) prognostic test which provides patients and their physicians a personalized determination of their risk for prostate cancer recurrence following removal of the prostate. The JCI article, now available online and in print describes Aureon's integrated Systems Pathology approach to generate highly accurate predictive tools for complex diseases such as prostate cancer. The article reviews data obtained in a cohort of 850 men with prostate cancer. Aureon scientists used machine learning tools to develop a m...
Success rates for prostate cancer depend on experience of surgeon
Jul-23-2007
Surgeons performing operations to remove patients' prostate glands -- the primary treatment for prostate cancer -- go through a steep learning curve, according to a study published online July 24 in the Journal of the National Cancer Institute. As the surgeons gain more experience performing the operation, called a radical prostatectomy, the chance that patients' prostate cancer will reoccur goes down.
Broccoli May Help Cut Prostate Cancer
Jul-24-2007
Title: Broccoli May Help Cut Prostate Cancer
Category: Health News
Created: 7/25/2007
Last Editorial Review: 7/25/2007
Category: Health News
Created: 7/25/2007
Last Editorial Review: 7/25/2007
Swapagift.com and the National Prostate Cancer Coalition Team Up this Father's Day to Make a Difference in Men's Health
Jul-28-2007
Swapagift.com Cards that Care™ program paves the way for unique and effective use of gift cards in the fight against prostate cancer. [PRWEB Jun 11, 2007]
Astrazeneca To Start Phase III Trials With ZD4054 - A Novel Treatment For Patients With Hormone Resistant Prostate Cancer
Jul-27-2007
AstraZeneca announced it will be moving its novel, oral agent ZD4054 into Phase III development in men with hormone resistant prostate cancer - a disease which affects approximately 60,000 new patients in the US alone each year.[i] The Phase III trial programme will begin before the end of 2007. [click link for full article]
Outcome of prostate cancer surgery depends on the experience of the surgeon
Jul-23-2007
According to a new study published online today in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.
Broccoli and cauliflower may slash prostate cancer risk
Jul-27-2007
"High intake of cruciferous vegetables, including broccoli and cauliflower, may be associated with reduced risk of aggressive prostate cancer"
Epidemiological and animal studies have shown that diets high in cruciferous vegetables result in less instances of certain cancers, especially lung, colon, breast and ovarian cancer, while the new study ...
Health news on prostate cancer Radioactive seed therapy can increase lifespan improve quality of life
Jul-27-2007
For the nearly 219000 men who will be diagnosed with Prostate Cancer this year the decision regarding how to treat it can be confusing However several recent studies comparing the most prevalent treatment options - including watchful waiting surgery external......
Swapagift.com and the National Prostate Cancer Coalition Team Up this Father's Day to Make a Difference in Men's Health
Jul-28-2007
Swapagift.com Cards that Care™ program paves the way for unique and effective use of gift cards in the fight against prostate cancer. (PRWeb Jun 11, 2007)
Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1NYWduLVN1bW0tU2luZy1UaGlyLVplcm8=
Surgeons’ Experience Matters, Study Finds
Jul-25-2007
Prostate cancer is less likely to relapse in men who are treated by more experienced surgeons, according to a new study.
Richard Franklin, director, 58
Jul-28-2007
Obituary: Aussie filmmaker co-produced 'Blue Lagoon' -- "Psycho II" and "Roadgames" helmer Richard Franklin died July 11 in Melbourne, Australia of prostate cancer.
Baptist Medical Center Creates New Web Page for Prostate Treatment Options in Mississippi
Jul-28-2007
In an effort to educate men on their prostate cancer treatment options in Mississippi, Baptist created a new web page to explain the variety of treatments. [PRWEB Jun 29, 2007]
Bob Monkhouse back from grave for cancer campaign
Jul-28-2007
A cinema and TV ad to raise public awareness about prostate cancer will feature comedian Bob Monkhouse. By Dan Bell.
What's Going On
Jul-27-2007
The Cancer Therapy and Research Center is offering a free educational prostate cancer seminar.
MicroRNA expression profiling in prostate cancer.
Jul-25-2007
Abstract MicroRNAs are small, endogenously expressed noncoding RNAs that negatively regulate expression of protein-coding genes at the translational level.